NCT04270409 Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04270175 Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04268498 A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04267913 Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial) Status WITHDRAWN Phase PHASE2
NCT04251715 mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04246047 Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04240054 Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency Status RECRUITING Phase PHASE2
NCT04225611 Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema Status RECRUITING Phase PHASE1/PHASE2
NCT04223661 Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy Status WITHDRAWN Phase PHASE2
NCT04217148 The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Status COMPLETED Phase PHASE2
NCT04216524 Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Status RECRUITING Phase PHASE2
NCT04209218 Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery Status RECRUITING Phase NA
NCT04208516 Continuous Nerve Block Block vs Combination of Single Block Plus Intravenous Lidocaine for Postoperative Pain. Status TERMINATED Phase PHASE4
NCT04205916 A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery Status RECRUITING Phase PHASE4
NCT04201769 Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin Status UNKNOWN Phase PHASE3
NCT04191616 Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet Status COMPLETED Phase PHASE2
NCT04189107 Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS Status COMPLETED Phase PHASE3
NCT04188431 Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children Status TERMINATED Phase PHASE4
NCT04182997 Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy Status RECRUITING Phase PHASE4